| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.6 |